World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
55
Citations
8526
World Ranking
3885
National Ranking
1511

Paul R. Rhomberg publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Paul R. Rhomberg sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 185 publications — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Paul R. Rhomberg D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Paul R. Rhomberg sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 55 D-Index — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Paul R. Rhomberg is affiliated with the University of Iowa in the United States, contributing extensively to the field of medicine. Their research primarily focuses on infectious diseases, with a significant emphasis on antifungal resistance and susceptibility.

The scientist's work covers several subfields of study including:

  • Infectious Diseases
  • Epidemiology
  • Neurology
  • Molecular Medicine
  • Pharmacology

Key research topics addressed by Paul R. Rhomberg involve:

  • Antifungal resistance and susceptibility
  • Fungal Infections and Studies
  • Antibiotic Resistance in Bacteria
  • Infectious Diseases and Mycology
  • Plant Pathogens and Fungal Diseases
  • Antimicrobial Resistance in Staphylococcus
  • Antibiotics Pharmacokinetics and Efficacy

Their recent published papers include:

  • "Activity of a Long-Acting Echinocandin, Rezafungin, and Comparator Antifungal Agents Tested against Contemporary Invasive Fungal Isolates (SENTRY Program, 2016 to 2018)" (2020) - Antimicrobial Agents and Chemotherapy
  • "Evaluation of Synergistic Activity of Isavuconazole or Voriconazole plus Anidulafungin and the Occurrence and Genetic Characterization of Candida auris Detected in a Surveillance Program" (2021) - Antimicrobial Agents and Chemotherapy
  • "Evaluation of Rezafungin Provisional CLSI Clinical Breakpoints and Epidemiological Cutoff Values Tested against a Worldwide Collection of Contemporaneous Invasive Fungal Isolates (2019 to 2020)" (2022) - Journal of Clinical Microbiology
  • "Impact of COVID-19 on the antifungal susceptibility profiles of isolates collected in a global surveillance program that monitors invasive fungal infections" (2022) - Medical Mycology
  • "Activities of Manogepix and Comparators against 1,435 Recent Fungal Isolates Collected during an International Surveillance Program (2020)" (2022) - Antimicrobial Agents and Chemotherapy

Frequent publication venues where Paul R. Rhomberg's work appears include:

  • Open Forum Infectious Diseases
  • Antimicrobial Agents and Chemotherapy
  • Journal of Clinical Microbiology
  • Diagnostic Microbiology and Infectious Disease
  • Neurocritical Care

Collaborations are notable with researchers such as:

  • Mariana Castanheira
  • Cecília G Carvalhaes
  • Michael A. Pfaller
  • Lalitagauri M. Deshpande
  • S. A. Messer

Best Publications

  • Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae in the United States during 1999–2000, Including a Comparison of Resistance Rates since 1994–1995

    Gary V. Doern;Kristopher P. Heilmann;Holly K. Huynh;Paul R. Rhomberg

  • Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999-2008).

    Paul R. Rhomberg;Ronald N. Jones

  • In vitro antimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria

    Akinobu Ito;Naoki Kohira;Samuel K. Bouchillon;Joshua West

  • Fluoroquinolone Resistance in Streptococcus pneumoniae in United States since 1994-1995

    Angela B. Brueggemann;Stacy L. Coffman;Paul Rhomberg;Holly Huynh

  • Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: report from the MYSTIC Program (1999-2005).

    Lalitagauri M. Deshpande;Paul R. Rhomberg;Helio S. Sader;Ronald N. Jones

  • Antimicrobial Activity of CXA-101, a Novel Cephalosporin Tested in Combination with Tazobactam against Enterobacteriaceae, Pseudomonas aeruginosa, and Bacteroides fragilis Strains Having Various Resistance Phenotypes

    Helio S. Sader;Paul R. Rhomberg;David J. Farrell;Ronald N. Jones

  • Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY Antifungal Surveillance Program (2013).

    Mariana Castanheira;Shawn A. Messer;Paul R. Rhomberg;Michael A. Pfaller

  • Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere.

    Janet I. Andrews;Daniel J. Diekema;Stephen K. Hunter;Paul R. Rhomberg

  • Effect of the β-Lactamase Inhibitor Vaborbactam Combined with Meropenem against Serine Carbapenemase-Producing Enterobacteriaceae

    Mariana Castanheira;Paul R. Rhomberg;Robert K. Flamm;Ronald N. Jones

  • Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values.

    Michael A Pfaller;Paul R Rhomberg;Shawn A Messer;Ronald N Jones

  • Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999–2001)

    Alan H. Mutnick;Paul R. Rhomberg;Helio S. Sader;Ronald N. Jones

  • Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus.

    Helio S. Sader;Paul R. Rhomberg;Ronald N. Jones

  • Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA).

    Paul R. Rhomberg;Thomas R. Fritsche;Helio S. Sader;Ronald N. Jones

  • Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.

    Mariana Castanheira;Lalitagauri M. Deshpande;Andrew P. Davis;Paul R. Rhomberg

  • Rapid emergence of blaCTX-M among Enterobacteriaceae in U.S. Medical Centers: molecular evaluation from the MYSTIC Program (2007).

    Mariana Castanheira;Rodrigo E. Mendes;Paul R. Rhomberg;Ronald N. Jones

  • Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates

    Michael A. Pfaller;Shawn A. Messer;Paul R. Rhomberg;Ronald N. Jones

  • Outbreak of Severe Pseudomonas aeruginosa Infections Caused by a Contaminated Drain in a Whirlpool Bathtub

    Yasmina F. Berrouane;Louise-Anne McNutt;Barry J. Buschelman;Paul R. Rhomberg

  • WCK 5222 (cefepime/zidebactam) antimicrobial activity tested against Gram-negative organisms producing clinically relevant β-lactamases.

    Helio S Sader;Paul R Rhomberg;Robert K Flamm;Ronald N Jones

  • Evaluation of Vancomycin Susceptibility Testing for Methicillin-Resistant Staphylococcus aureus: Comparison of Etest and Three Automated Testing Methods

    Michael J. Rybak;Celine Vidaillac;Helio S. Sader;Paul R. Rhomberg

  • In Vitro Activities of Isavuconazole and Comparator Antifungal Agents Tested against a Global Collection of Opportunistic Yeasts and Molds

    Michael A. Pfaller;Shawn A. Messer;Paul R. Rhomberg;Ronald N. Jones

Frequent Co-Authors

Ronald N. Jones
Ronald N. Jones JMI Laboratories
Helio S. Sader
Helio S. Sader JMI Laboratories
Robert K. Flamm
Robert K. Flamm JMI Laboratories
Mariana Castanheira
Mariana Castanheira JMI Laboratories
Michael A. Pfaller
Michael A. Pfaller JMI Laboratories
Rodrigo E. Mendes
Rodrigo E. Mendes JMI Laboratories
Shawn A. Messer
Shawn A. Messer Oregon Health & Science University
David J. Farrell
David J. Farrell University Hospital Southampton NHS Foundation Trust
Thomas R. Fritsche
Thomas R. Fritsche Marshfield Clinic
Gary V. Doern
Gary V. Doern University of Iowa

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond microbiology, there are various online degree options and career pathways in the healthcare sector. Programs like fast online medical billing and coding certification programs offer a quick entry into healthcare administration, complementing scientific knowledge with essential coding and billing skills.

Students aspiring to broader medical roles can explore numerous online healthcare degrees that provide flexible learning environments suited for working professionals. These programs can serve as a strong foundation for various medical careers related to microbiology and healthcare.

For those interested in public health, pursuing an easy MPH online programs can be a strategic option. These programs often focus on practical skills and can lead to leadership roles in global and community health initiatives.

Alternatively, careers such as becoming a child life specialist provide unique opportunities to apply scientific knowledge to support the well-being of children and families in medical settings. This pathway highlights how microbiology and healthcare studies can merge with compassionate, patient-centered care.

Best Scientists Citing Paul R. Rhomberg

Trending Scientists

Recently Published Articles